ACUTA CAPITAL PARTNERS, LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 260 filers reported holding SAGE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
ACUTA CAPITAL PARTNERS, LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$2,894,000
-67.4%
50,945
-57.0%
1.16%
-63.9%
Q1 2021$8,870,000
-59.9%
118,500
-53.7%
3.20%
-46.9%
Q4 2020$22,129,000
+60.9%
255,800
+13.7%
6.02%
+61.2%
Q3 2020$13,752,000
+867.8%
225,000
+1025.0%
3.74%
+1008.3%
Q1 2017$1,421,000
+44.4%
20,000
+18.5%
0.34%
-28.5%
Q4 2015$984,000
+144.8%
16,877
+111.0%
0.47%
+38.9%
Q1 2015$402,0008,0000.34%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders